ImaRx Therapeutics (Urokinase Business) Overview
ImaRx Therapeutics (Urokinase Business) General Information
Description
Manufacturer of bio pharmaceutical products. The company manufactures thrombolytic which is used in treatment of acute massive pulmonary embolism.
Want to dig into this profile?
We’ll help you find what you need
Learn more
ImaRx Therapeutics (Urokinase Business) Valuation & Funding
| Deal Type |
Date |
Amount |
Valuation/
EBITDA |
Post-Val |
Status |
Debt |
This information is available in the PitchBook Platform. To explore ImaRx Therapeutics (Urokinase Business)‘s full profile, request access.
Request a free trial
ImaRx Therapeutics (Urokinase Business) Former Investors
| Investor Name |
Investor Type |
Holding |
Investor Since |
Participating Rounds |
Contact Info |
This information is available in the PitchBook Platform. To explore ImaRx Therapeutics (Urokinase Business)‘s full profile, request access.
Request a free trial